-
Caspase-3 Fluorometric Assay Kit in RCC
2026-09-01
The Caspase-3 Fluorometric Assay Kit provides a quantitative way to connect DEVD-dependent enzyme activity with apoptotic mechanism. This guide uses renal cell carcinoma research to explain assay design, controls, interpretation, and limitations.
-
Nanoparticle Uptake by Human Corneal Epithelial Cells
2026-09-01
Azadi and David examined how PLGA nanoparticle size and surface chemistry influence uptake by human corneal epithelial cells in a mucosa-aware in vitro model. Their findings identify energy-dependent endocytosis, particularly macropinocytosis and caveolae-mediated uptake, as central mechanisms and provide practical design guidance for topical ocular nanomedicines.
-
L-Glutathione Reduced in Redox Assays
2026-08-31
L-Glutathione Reduced is more than a generic antioxidant: it is a mechanistically informative reagent for redox, GST, and cancer-metabolism workflows. This guide connects glutathione chemistry with GOT1 research to improve assay controls, interpretation, and experimental reproducibility.
-
Dual-Action Inhibitors Tune p38α Dephosphorylation
2026-08-31
The reference preprint shows that some kinase inhibitors do more than occupy the p38α catalytic site: they also stabilize an activation-loop conformation that exposes phospho-threonine to the WIP1 phosphatase. This structure-guided mechanism offers a framework for interpreting p38 inhibition through both catalytic blockade and accelerated molecular reset.
-
Substrate Stiffness, FAK, and Dentinogenesis
2026-08-30
This study identifies a LAMB1–FAK–MEK1/2 signaling axis that links substrate stiffness to odontoblast-like cell extension and dentinogenic differentiation. Its findings support a mechanistic framework for designing cell–material interfaces in reparative dentin and dental tissue engineering.
-
Estradiol Benzoate Assay Workflows
2026-08-29
Build more reproducible ERα binding and signaling experiments with a high-purity synthetic estradiol analog. This guide connects practical stock preparation, quantitative assay design, cross-species receptor testing, and troubleshooting to defensible estrogen receptor research.
-
Griseofulvin in Microtubule Mechanism Assays
2026-08-28
Use Griseofulvin as a DMSO-compatible microtubule probe for fungal cell studies, viability experiments, and mechanism-focused aneugen screening. This workflow separates broad cytotoxicity from microtubule disruption by combining timed exposure, flow-cytometry biomarkers, and orthogonal controls.
-
GANT61 Workflows for GLI-Driven Cancer Research
2026-08-28
GANT61 is a practical GLI inhibitor for testing whether GLI1/2 activity sustains malignant growth, ferroptosis resistance, or cisplatin insensitivity. This workflow connects pathway-level pharmacology with GLI2–PRDX1 validation in bladder cancer and provides formulation, dosing, and troubleshooting guidance for translational cancer research.
-
Merbromin as a Selective SARS-CoV-2 3CLpro Inhibitor
2026-08-27
Chen and colleagues identified Merbromin as a selective in vitro inhibitor of the SARS-CoV-2 chymotrypsin-like protease 3CLpro through screening of approximately 6,000 compounds. Kinetic, binding, and docking analyses supported a mixed-type inhibition model involving more than one interaction site, providing a mechanistic starting point for antiviral inhibitor development.
-
BEND Lipids for mRNA Delivery and Gene Editing
2026-08-27
The reference study introduces branched endosomal disruptor (BEND) ionizable lipids that improve lipid nanoparticle delivery of mRNA and CRISPR-Cas9 ribonucleoproteins. Its complementary hepatic and T-cell experiments link terminal lipid branching to stronger endosomal penetration, enhanced transfection, and more effective gene editing compared with non-branched lipid designs.
-
iPSC-Based Trial Selection for Ultrarare Disease
2026-08-26
Sequiera et al. developed a patient-specific iPSC platform to prescreen therapies for an 18-year-old with Leigh-like syndrome caused by ultrarare ECHS1 variants. The study shows how matched patient and control models can reduce uncertainty before clinical trial enrollment, although broader validation is needed before routine clinical adoption.
-
Nigericin Sodium Salt: Practical Workflow
2026-08-26
Nigericin sodium salt is a potassium ionophore for controlled K+/H+ exchange across biological membranes, supporting experiments on cytoplasmic pH regulation, platelet aggregation modulation, and lead (Pb2+) ion transport. This dossier-based guide covers preparation and assay controls, while emphasizing that the compound is for research use only and is not a validated treatment for lead intoxication or a universal reagent for every cell model.
-
Mitoxantrone Targets the ERα DBD–LBD Interface
2026-08-25
Wang et al. identify mitoxantrone as a ligand for an underexplored interface between the estrogen receptor alpha DNA-binding and ligand-binding domains. The study shows that this interaction alters receptor conformation, promotes cytoplasmic redistribution and proteasomal degradation, and suppresses endocrine-resistant ERα activity through a mechanism distinct from DNA damage.
-
Asunaprevir Workflows for HCV NS3 Research
2026-08-25
Asunaprevir (BMS-650032) supports a practical, tiered workflow spanning NS3/4A protease biochemistry, HCV RNA replication inhibition, genotype profiling, and host-response controls. This guide combines product-specific handling advice with a reporter-first screening concept from a separate cancer study, while clearly distinguishing established evidence from assay-development recommendations.
-
EdU Imaging Kits (Cy5) for S-Phase Assays
2026-08-24
Measure DNA synthesis with a morphology-preserving click-chemistry workflow designed for fluorescence microscopy and flow cytometry. EdU Imaging Kits (Cy5) offer a practical alternative to BrdU assays when researchers need sensitive proliferation data alongside intact antigen-binding sites.